BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 37299411)

  • 61. A novel nitidine chloride nanoparticle overcomes the stemness of CD133
    Li D; Zhang Q; Zhou Y; Zhu H; Li T; Du F
    BMC Pharmacol Toxicol; 2022 Jul; 23(1):48. PubMed ID: 35820920
    [TBL] [Abstract][Full Text] [Related]  

  • 62. 9-bis[2-(pyrrolidin-1-yl)ethoxy]-6-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}-11H-indeno[1, 2-c]quinolin-11-one (BPIQ), A Quinoline Derivative Inhibits Human Hepatocellular Carcinoma Cells by Inducing ER Stress and Apoptosis.
    Chang WT; Fong Y; Chuang SC; Chou CK; Chou HL; Yang CF; Tseng CH; Chen YL; Chiu CC
    Anticancer Agents Med Chem; 2017; 17(5):692-700. PubMed ID: 27491935
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Sensitization of TRAIL-induced cell death by 20(S)-ginsenoside Rg3 via CHOP-mediated DR5 upregulation in human hepatocellular carcinoma cells.
    Lee JY; Jung KH; Morgan MJ; Kang YR; Lee HS; Koo GB; Hong SS; Kwon SW; Kim YS
    Mol Cancer Ther; 2013 Mar; 12(3):274-85. PubMed ID: 23053497
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Hsp90 inhibitor SNX-2112 induces apoptosis of human hepatocellular carcinoma cells: the role of ER stress.
    Wang X; Wang S; Liu Y; Ding W; Zheng K; Xiang Y; Liu K; Wang D; Zeng Y; Xia M; Yang D; Wang Y
    Biochem Biophys Res Commun; 2014 Mar; 446(1):160-6. PubMed ID: 24582562
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Potentiation of TRAIL‑induced cell death by nonsteroidal anti‑inflammatory drug in human hepatocellular carcinoma cells through the ER stress‑dependent autophagy pathway.
    Lee SH; Moon HJ; Lee YS; Kang CD; Kim SH
    Oncol Rep; 2020 Sep; 44(3):1136-1148. PubMed ID: 32705218
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Stearoyl-CoA desaturase regulates sorafenib resistance via modulation of ER stress-induced differentiation.
    Ma MKF; Lau EYT; Leung DHW; Lo J; Ho NPY; Cheng LKW; Ma S; Lin CH; Copland JA; Ding J; Lo RCL; Ng IOL; Lee TKW
    J Hepatol; 2017 Nov; 67(5):979-990. PubMed ID: 28647567
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
    Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
    Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma.
    Yoo JJ; Yu SJ; Na J; Kim K; Cho YY; Lee YB; Cho EJ; Lee JH; Kim YJ; Youn H; Yoon JH
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875800
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Meloxicam combined with sorafenib synergistically inhibits tumor growth of human hepatocellular carcinoma cells via ER stress-related apoptosis.
    Zhong J; Xiu P; Dong X; Wang F; Wei H; Wang X; Xu Z; Liu F; Li T; Wang Y; Li J
    Oncol Rep; 2015 Oct; 34(4):2142-50. PubMed ID: 26252057
    [TBL] [Abstract][Full Text] [Related]  

  • 70. V8, a newly synthetic flavonoid, induces apoptosis through ROS-mediated ER stress pathway in hepatocellular carcinoma.
    Zhang Y; Zhao L; Li X; Wang Y; Yao J; Wang H; Li F; Li Z; Guo Q
    Arch Toxicol; 2014 Jan; 88(1):97-107. PubMed ID: 23835921
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A positive feedback loop between Periostin and TGFβ1 induces and maintains the stemness of hepatocellular carcinoma cells via AP-2α activation.
    Chen G; Wang Y; Zhao X; Xie XZ; Zhao JG; Deng T; Chen ZY; Chen HB; Tong YF; Yang Z; Ding XW; Guo PY; Yu HT; Wu LJ; Zhang SN; Zhu QD; Li JJ; Shan YF; Yu FX; Yu ZP; Xia JL
    J Exp Clin Cancer Res; 2021 Jun; 40(1):218. PubMed ID: 34193219
    [TBL] [Abstract][Full Text] [Related]  

  • 72. HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma.
    Lin X; Zuo S; Luo R; Li Y; Yu G; Zou Y; Zhou Y; Liu Z; Liu Y; Hu Y; Xie Y; Fang W; Liu Z
    Theranostics; 2019; 9(25):7583-7598. PubMed ID: 31695788
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prodigiosin activates endoplasmic reticulum stress cell death pathway in human breast carcinoma cell lines.
    Pan MY; Shen YC; Lu CH; Yang SY; Ho TF; Peng YT; Chang CC
    Toxicol Appl Pharmacol; 2012 Dec; 265(3):325-34. PubMed ID: 22982536
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cellular retinol binding protein-1 inhibits cancer stemness via upregulating WIF1 to suppress Wnt/β-catenin pathway in hepatocellular carcinoma.
    Liu X; Shan W; Li T; Gao X; Kong F; You H; Kong D; Qiao S; Tang R
    BMC Cancer; 2021 Nov; 21(1):1224. PubMed ID: 34775955
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Oxidative stress mediated Ca(2+) release manifests endoplasmic reticulum stress leading to unfolded protein response in UV-B irradiated human skin cells.
    Farrukh MR; Nissar UA; Afnan Q; Rafiq RA; Sharma L; Amin S; Kaiser P; Sharma PR; Tasduq SA
    J Dermatol Sci; 2014 Jul; 75(1):24-35. PubMed ID: 24794973
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Melatonin reverses tunicamycin-induced endoplasmic reticulum stress in human hepatocellular carcinoma cells and improves cytotoxic response to doxorubicin by increasing CHOP and decreasing survivin.
    Fan L; Sun G; Ma T; Zhong F; Lei Y; Li X; Wei W
    J Pineal Res; 2013 Sep; 55(2):184-94. PubMed ID: 23711089
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Next-generation proteasome inhibitor oprozomib synergizes with modulators of the unfolded protein response to suppress hepatocellular carcinoma.
    Vandewynckel YP; Coucke C; Laukens D; Devisscher L; Paridaens A; Bogaerts E; Vandierendonck A; Raevens S; Verhelst X; Van Steenkiste C; Libbrecht L; Geerts A; Van Vlierberghe H
    Oncotarget; 2016 Jun; 7(23):34988-5000. PubMed ID: 27167000
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Patient pIgR-enriched extracellular vesicles drive cancer stemness, tumorigenesis and metastasis in hepatocellular carcinoma.
    Tey SK; Wong SWK; Chan JYT; Mao X; Ng TH; Yeung CLS; Leung Z; Fung HL; Tang AHN; Wong DKH; Mak LY; Yuen MF; Sin CF; Ng IO; Ma SKY; Lee TKW; Cao P; Zhong K; Gao Y; Yun JP; Yam JWP
    J Hepatol; 2022 Apr; 76(4):883-895. PubMed ID: 34922977
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Anti‑cancer effects of a novel Pan‑RAF inhibitor in a hepatocellular carcinoma cell line.
    Wang W; Xu B; Li Q; Jiang D; Yan S
    Mol Med Rep; 2018 Apr; 17(4):6185-6193. PubMed ID: 29484394
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prospective impact of 5-FU in the induction of endoplasmic reticulum stress, modulation of GRP78 expression and autophagy in Sk-Hep1 cells.
    Yadunandam AK; Yoon JS; Seong YA; Oh CW; Kim GD
    Int J Oncol; 2012 Sep; 41(3):1036-42. PubMed ID: 22684338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.